TY  - CHAP

T1  - The Utility of a Controlled Human Infection Model for Developing Leishmaniasis Vaccines

T2  - Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges

UR  - http://dx.doi.org/10.1007/978-3-031-24355-4_12

PY  - 2023/01/01

AU  - Kaye PM

AU  - Parkash V

AU  - Layton AM

AU  - Lacey CJN

ED  - 

DO  - DOI: 10.1007/978-3-031-24355-4_12

PB  - Springer International Publishing

SN  - 9783031243547

SP  - 263

EP  - 279

Y2  - 2024/12/22

ER  -